| Literature DB >> 35805621 |
Pablo Hernández-Franco1, María Maldonado-Vega2, José Víctor Calderón-Salinas3, Emilio Rojas1, Mahara Valverde1.
Abstract
Exposure to lead in environmental and occupational settings continues to be a serious public health problem. At environmentally relevant doses, two mechanisms may underlie lead exposition-induced genotoxicity, disruption of the redox balance and an interference with DNA repair systems. The aim of the study was to evaluate the ability of lead exposition to induce impaired function of Ape1 and its impact on DNA repair capacity of workers chronically exposed to lead in a battery recycling plant. Our study included 53 participants, 37 lead exposed workers and 16 non-lead exposed workers. Lead intoxication was characterized by high blood lead concentration, high lipid peroxidation and low activity of delta-aminolevulinic acid dehydratase (δ-ALAD). Relevantly, we found a loss of DNA repair capacity related with down-regulation of a set of specific DNA repair genes, showing specifically, for the first time, the role of Ape1 down regulation at transcriptional and protein levels in workers exposed to lead. Additionally, using a functional assay we found an impaired function of Ape1 that correlates with high blood lead concentration and lipid peroxidation. Taken together, these data suggest that occupational exposure to lead could decrease DNA repair capacity, inhibiting the function of Ape1, as well other repair genes through the regulation of the ZF-transcription factor, promoting the genomic instability.Entities:
Keywords: Ape1 activity; DNA-repair capacity; ZF-TF; comet assay; lead exposed workers; stress and toxicity gene profile
Mesh:
Substances:
Year: 2022 PMID: 35805621 PMCID: PMC9265680 DOI: 10.3390/ijerph19137961
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Main characteristics of lead exposed and non-exposed workers (mean ± SD).
| Variables | Non-Exposed (16) | Lead Exposed (37) |
|---|---|---|
| Age (years) | 37.15 ± 7.09 | 31.65 ± 8.56 |
| Duration of exposed (years) | - | 4.53 ± 3.29 |
| Smoking (%) | 18.70 | 16.00 |
| Blood lead concentration (µg/dL) | 1.42 ± 0.87 | 69.25 ± 24.95 *** |
| ALAD activity (nmol/mL/h) | 567.70 ± 46.20 | 312.86 ± 27.99 *** |
| MDA (nmol/mL) | 0.87 ± 0.03 | 1.52 ± 0.08 |
*** p < 0.001.
Figure 1Occupational lead exposure decreases DNA repair capacity. Comet assay was performed from each individual (lead exposed and non-exposed workers), to show basal DNA damage; immediately after inflicting DNA damage with ionizing radiation (3Gy) and after 60 min, to determine DNA-repair capacity. Data are means ± S.E of 16 non-exposed and 37 lead exposed workers. One way ANOVA with Tukey HSD pos hoc test was performed with respect to the basal damage of both exposure groups. *** p < 0.0001.
Stress and Toxicity Gene expression changes in lead exposure workers and p values by t Test.
| # | Gene | Exposed/NonExposed | FC | # | Gene | Exposed/Non Exposed | FC | # | Gene | Exposed/Non Exposed | FC | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANXAS | 1.361 | 0.445 | 0.180 | 38 | GSR | 0.583 | −0.778 | 0.001 | 75 | PTGS2 | 1.347 | 0.429 | 0.128 |
| 2 | ATM | 0.850 | −0.234 | 0.224 | 39 | GSTM3 | 0.649 | −0.623 | 0.005 | 76 | RAD23A | 1.307 | 0.386 | 0.146 |
| 3 | BAX | 1.374 | 0.459 | 0.132 | 40 | HMOX1 | 0.546 | −0.873 | 0.001 | 77 | RAD50 | 0.883 | −0.179 | 0.257 |
| 4 | BCL2L1 | 1.046 | 0.064 | 0.413 | 41 | HMOX2 | 1.807 | 0.853 | 0.072 | 78 | CCL21 | 0.759 | −0.397 | 0.073 |
| 5 | BCL2L2 | 0.868 | −0.204 | 0.254 | 42 | HSF1 | 1.689 | 0.756 | 0.050 | 79 | CCL3 | 0.799 | −0.324 | 0.161 |
| 6 | CASPS | 0.836 | −0.258 | 0.182 | 43 | HSPH1 | 1.162 | 0.216 | 0.306 | 80 | CCL4 | 0.609 | −0.716 | 0.013 |
| 7 | CASP10 | 0.862 | −0.215 | 0.257 | 44 | HSPA1A | 1.074 | 0.103 | 0.395 | 81 | CXCL10 | 1.728 | 0.789 | 0.012 |
| 8 | CASP8 | 0.660 | −0.599 | 0.036 | 45 | PTGS1 | 0.657 | −0.607 | 0.004 | 82 | SERPINE1 | 1.565 | 0.646 | 0.041 |
| 9 | CAT | 1.752 | 0.809 | 0.071 | 46 | HSPA1L | 0.601 | −0.734 | 0.000 | 83 | SOD1 | 1.373 | 0.457 | 0.067 |
| 10 | CCNC | 1.521 | 0.605 | 0.095 | 47 | HSPA2 | 0.684 | −0.548 | 0.017 | 84 | SOD2 | 0.910 | −0.135 | 0.246 |
| 11 | CCND1 | 1.280 | 0.356 | 0.210 | 48 | HSPA4 | 0.582 | −0.780 | 0.004 | 85 | TNF | 0.707 | −0.500 | 0.011 |
| 12 | CCNG1 | 0.902 | −0.149 | 0.346 | 49 | HSPA5 | 1.682 | 0.750 | 0.094 | 86 | TNFRSF1A | 0.807 | −0.309 | 0.156 |
| 13 | CDKN1A | 0.728 | −0.458 | 0.075 | 50 | HSPA6 | 1.699 | 0.764 | 0.065 | 87 | TNFSF10 | 0.718 | −0.478 | 0.067 |
| 14 | CHEK2 | 0.831 | −0.268 | 0.166 | 51 | HSPA8 | 1.150 | 0.202 | 0.297 | 88 | FASLG | 0.608 | −0.718 | 0.011 |
| 15 | CRYAB | 1.297 | 0.375 | 0.157 | 52 | HSPA9B | 0.937 | −0.093 | 0.411 | 89 | TP53 | 1.332 | 0.413 | 0.079 |
| 16 | CSF2 | 0.884 | −0.178 | 0.307 | 53 | HSPAB1 | 0.593 | −0.753 | 0.000 | 90 | TRADD | 1.439 | 0.525 | 0.017 |
| 17 | CYP1A1 | 1.495 | 0.580 | 0.120 | 54 | HSPCA | 0.577 | −0.792 | 0.000 | 91 | UGT1A4 | 0.841 | −0.250 | 0.167 |
| 18 | CYP1B1 | 1.638 | 0.712 | 0.086 | 55 | HSPCB | 0.709 | −0.495 | 0.013 | 92 | UNG | 0.676 | −0.565 | 0.007 |
| 19 | CYP2E1 | 1.142 | 0.191 | 0.349 | 56 | HSPD1 | 0.622 | −0.684 | 0.003 | 93 | XRCC1 | 0.638 | −0.648 | 0.000 |
| 20 | CYP7A1 | 0.837 | −0.256 | 0.283 | 57 | HSPE1 | 1.216 | 0.282 | 0.242 | 94 | XRCC2 | 0.745 | −0.424 | 0.073 |
| 21 | CYP7B1 | 0.714 | −0.486 | 0.052 | 58 | IGFBP6 | 1.774 | 0.827 | 0.044 | 95 | XRCC4 | 0.900 | −0.151 | 0.312 |
| 22 | DDB1 | 0.749 | −0.417 | 0.059 | 59 | IL1B | 0.976 | −0.036 | 0.462 | 96 | XRCC5 | 0.788 | −0.344 | 0.165 |
| 23 | DDIT3 | 0.959 | −0.061 | 0.430 | 60 | IL1A | 0.988 | −0.017 | 0.483 | 97 | PUC18 | 1.271 | 0.346 | 0.172 |
| 24 | DNA1A1 | 0.678 | −0.561 | 0.032 | 61 | 1L1B | 0.631 | −0.664 | 0.003 | 98 | PUC18 | 1.232 | 0.301 | 0.148 |
| 25 | DNAJB4 | 0.796 | −0.328 | 0.163 | 62 | 1L6 | 0.712 | −0.490 | 0.020 | 99 | PUC18 | 0.920 | −0.120 | 0.303 |
| 26 | E2F1 | 1.431 | 0.517 | 0.118 | 63 | LTA | 0.739 | −0.436 | 0.072 | 103 | GAPDH | 1.032 | 0.046 | 0.430 |
| 27 | EGR1 | 1.015 | 0.022 | 0.478 | 64 | MDM2 | 0.643 | −0.636 | 0.020 | 104 | GAPDH | 0.950 | −0.074 | 0.402 |
| 28 | EPHX2 | 0.749 | −0.417 | 0.175 | 65 | MIF | 1.607 | 0.684 | 0.072 | 109 | RPL13A | 0.837 | −0.256 | 0.117 |
| 29 | ERCC1 | 0.712 | −0.490 | 0.080 | 66 | PRDX1 | 1.928 | 0.947 | 0.020 | 110 | RPL13A | 0.875 | −0.193 | 0.289 |
| 30 | ERCC3 | 0.655 | −0.611 | 0.008 | 67 | PRDX2 | 1.314 | 0.394 | 0.078 | 111 | ACTB | 0.933 | −0.101 | 0.383 |
| 31 | ERCC4 | 0.640 | −0.643 | 0.007 | 68 | MT2A | 1.101 | 0.138 | 0.030 | 112 | ACTB | 0.868 | 0.204 | 0.280 |
| 32 | ERCC5 | 0.584 | −0.777 | 0.004 | 69 | NFKB1 | 0.770 | −0.377 | 0.060 | |||||
| 33 | FM01 | 1.274 | 0.350 | 0.210 | 70 | NFKB1A | 0.753 | −0.409 | 0.054 | |||||
| 34 | FM05 | 1.592 | 0.671 | 0.059 | 71 | NOS2A | 0.668 | −0.583 | 0.025 | |||||
| 35 | GADD45A | 1.013 | 0.019 | 0.482 | 72 | PCNA | 0.591 | −0.759 | 0.009 | |||||
| 36 | GADD5B | 1.053 | 0.074 | 0.427 | 73 | GDF15 | 1.915 | 0.937 | 0.028 | |||||
| 37 | GPX1 | 0.736 | −0.441 | 0.036 | 74 | POR | 1.924 | 0.944 | 0.010 |
Genes included in the Stress and Toxicity GE-Array, FC = fold change after normalization with respect to PPIA. # Genes are listed by array position; it is important to mention that APE1 in not included into the array.
Stress and Toxicity genes down or up regulated. Genes that presented a log2 value greater than −0.86 with p < 0.05, which is 45 % change, were considered down-regulated genes. While those genes that presented a log2 value greater than 0.53 with p < 0.5, which also is 45 % of changes, were considered upregulated.
| Gene | Lead Exposed/Non Exposed | Fold Change log2 | Up/Down | |
|---|---|---|---|---|
| HSPCA | 0.577 | −0.792 | 6.8 × 10−5 | Down |
| HSPA4 | 0.582 | −0.780 | 0.004 | Down |
| GSR | 0.583 | −0.778 | 0.001 | Down |
| ERCC5 | 0.584 | −0.777 | 0.004 | Down |
| PCNA | 0.591 | −0.759 | 0.009 | Down |
| HSPB1 | 0.593 | −0.753 | 0.000 | Down |
| HSPA1L | 0.601 | −0.734 | 0.000 | Down |
| FASLG | 0.608 | −0.718 | 0.011 | Down |
| CCL4 | 0.609 | −0.716 | 0.013 | Down |
| HSPD1 | 0.622 | −0.684 | 0.003 | Down |
| IL1B | 0.631 | −0.664 | 0.003 | Down |
| XRCC1 | 0.638 | −0.648 | 0.000 | Down |
| ERCC4 | 0.640 | −0.643 | 0.007 | Down |
| MDM2 | 0.643 | −0.636 | 0.020 | Down |
| GSTM3 | 0.649 | −0.623 | 0.005 | Down |
| ERCC3 | 0.655 | −0.611 | 0.008 | Down |
| PTGS1 | 0.657 | −0.607 | 0.004 | Down |
| CASP8 | 0.660 | −0.599 | 0.036 | Down |
| NOS2A | 0.668 | −0.583 | 0.025 | Down |
| UNG | 0.676 | −0.565 | 0.007 | Down |
| DNAJA1 | 0.678 | −0.561 | 0.032 | Down |
| HSPA2 | 0.684 | −0.548 | 0.017 | Down |
| TNF | 0.707 | −0.500 | 0.011 | Down |
| HSPCB | 0.709 | −0.495 | 0.013 | Down |
| IL6 | 0.712 | −0.490 | 0.020 | Down |
| CYP7B1 | 0.714 | −0.486 | 0.050 | Down |
| GPX1 | 0.736 | −0.441 | 0.036 | Down |
| NFKBIA | 0.753 | −0.409 | 0.050 | Down |
| SERPINE1 | 1.565 | 0.646 | 0.041 | Up |
| HSF1 | 1.689 | 0.756 | 0.050 | Up |
| CXCL10 | 1.728 | 0.789 | 0.012 | Up |
| IGFBP6 | 1.774 | 0.827 | 0.044 | Up |
| GDF15 | 1.915 | 0.937 | 0.028 | Up |
| POR | 1.924 | 0.944 | 0.010 | Up |
| PRDX1 | 1.928 | 0.947 | 0.030 | UP |
Figure 2Occupational lead exposure decreases APE1/Ref1 mRNA level. mRNA extracts were prepared from lymphocytes of lead exposed and non-exposed workers and analyzed by semi-quantitative RT-PCR analysis of APE1/Ref1. (A) Representative gel image (C1–C4) of 16 non-exposed workers and representative image (E1–E4) of workers exposed to lead of all group of 37 workers. (B) Bar graphs showing relative densitometry quantification, data were normalized to GAPDH and represented as % as compared to control. Data are means ± S.E of three independent mRNA gels, of all samples. Mann–Whitney t-test *** p < 0.0001.
Figure 3Occupational lead exposure decreases the protein level of Ape1. From total proteins extracted from lymphocytes of lead-exposed and non-exposed workers, APE1 immuno-blot was performed. (A) Representative immuno-blots (C1–C6) for Ape1 of all non-exposed workers (n = 16) and representative immuno-blots (E1–E6) of all lead exposed workers (n = 37). (B) Bar graphs show relative densitometry quantification, data was normalized to β-Actin and represented as % as compared to control. Data are means ± S.E of at least three independent western blots of all workers involved into the bio-monitoring. Mann–Whitney t-test. ** p < 0.01.
Figure 4Decreased Ape1 functionality in lead exposure workers. Ape1 endonuclease catalytic activity was evaluated by molecular beacons-based assay in cell-free extracts from non-exposed and lead exposed workers. (A) Data in graph is represented as relative fluorescence units. Data are the fluorescence values of the reaction product of molecular beacon at 15 and 30 min of each lead-exposed worker. Line represents average relative fluorescence units of the non-exposed workers. Mann–Whitney t-test *** p < 0.0001. (B) Fluorescence quantification, represented as Mean ± SE of all unexposed workers, being those that show the highest Ape1 activity. We also show data for workers exposed to lead at 15 and 30 min.
In silico prediction of binding sites for different transcription factors.
| Transcription Factors Families | Predicted Number of Downregulated Target Genes | Predicted Number of DNA Repair Genes |
|---|---|---|
| CEBP (Basic leucine zipper factors (bZIP)) | 16 | 6 |
| SOX (High/mobility group (HMG) domain | 16 | 13 |
| HOX and POU (Home o domain factors) | 38 | 24 |
| FOS (Basic leucine zipper factors (bZIP)) | 20 | 17 |
| MYC (Basic helix-loop/helix factors (bHLH)) | 21 | 18 |
| E2F (Fork head/winged helix factors) | 24 | 24 |
| ELF/ELK (Tryptophan cluster factors) | 26 | 22 |
| Zn–TF (C2H2 zinc finger factors and nuclear receptors with C4 zinc finger) | 140 | 72 |
| TOTAL | 1014 | 764 |
Pearson’s correlation coefficient (r) between oxidative markers of lead exposure and different Ape1 parameters in workers at a battery recycling plant.
| δ-ALAD Activity | [MDA] | Ape1 Activity | APE1 mRNA | Ape1 Protein | |
|---|---|---|---|---|---|
| [PbB] | −0.72 *** | 0.60 *** | −0.43 *** | −0.53 *** | −0.24 ** |
| δ-ALAD activity | −0.52 *** | 0.38 ** | 0.31 ** | NS | |
| [MDA] | −0.33 ** | 0.31 ** | NS | ||
| Ape1 activity | 0.37 ** | NS | |||
| APE1 mRNA | NS |
** p < 0.01, *** p < 0.001, NS Not significant.